i3 cancers showed higher expression of downstream MAPK components (DUSP4 and ETV5) and i2 cancers had overexpression of EGFR ligands, AREG and EREG (Fig. 5b and Extended Data Fig. 7c). Here, ETV5 is linked to cancer.